Medtronic plc MDT recently shared a comprehensive set of new data emphasizing the benefits of the MiniMed 780G insulin pump system. The latest findings demonstrate how the system addresses ...
The US Food and Drug Administration (FDA) has approved the MiniMed 770G (Medtronic) automated insulin delivery system for children aged 2 to 6 years. The 770G will also be available to older children ...
With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback